In Re Cardinal Health, Inc. Securities Litigation

365 F. Supp. 2d 866, 2005 U.S. Dist. LEXIS 3042, 2005 WL 894693
CourtDistrict Court, S.D. Ohio
DecidedMarch 1, 2005
DocketMaster File C2-04-575
StatusPublished
Cited by3 cases

This text of 365 F. Supp. 2d 866 (In Re Cardinal Health, Inc. Securities Litigation) is published on Counsel Stack Legal Research, covering District Court, S.D. Ohio primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
In Re Cardinal Health, Inc. Securities Litigation, 365 F. Supp. 2d 866, 2005 U.S. Dist. LEXIS 3042, 2005 WL 894693 (S.D. Ohio 2005).

Opinion

ORDER

MARBLEY, District Judge.

I. INTRODUCTION

This matter comes before the Court on Defendants’ Motion For Partial Stay of Overlapping State Court Proceedings. [Docket No. 123]. Specifically, Defendants request a stay of all proceedings and/or discovery in the state-court derivative action relating to the accounting issues raised in the federal securities complaints. The Court GRANTS Defendants’ Motion *870 to stay all discovery in the state court case relating to the accounting issues raised in the federal securities complaints. This stay shall remain in effect pending this Court’s disposition of any motion to dismiss the ongoing consolidated federal securities case, In re Cardinal Health Securities Litigation, No. C2-04-575 (S.D. Ohio filed July 2, 2004).

II. BACKGROUND and PROCEDURAL HISTORY

The consolidated federal securities case pending in this Court consists of putative class actions against Cardinal Health, Inc. (“Cardinal” or “the Company”), its officers, and related parties. The claims arise from announcements in July 2004 that the Company was the subject of a federal criminal investigation and that its Chief Financial Officer had resigned. After these announcements, the price of the Company’s stock fell, and several class actions were filed alleging various violations of the federal securities laws, including Section 11 of the' Securities Exchange Act of * 1933, 15 U.S.C. § 77k, Sections 10(b) and 20(a) of the Securities and Exchange Act of 1934, 15 -U.S.C. §§ 78j(b) and 78t(a), and Rule 10b-5 promulgated thereunder, 17 C.F.R. § 240.10b-5. 1

Pursuant to the Private Securities Litigation Reform Act (“PSLRA”), 104-67,109 Stat. 737, this Court consolidated all securities class actions filed against Cardinal and related Defendants on December 16, 2004 2 and appointed Lead Plaintiff and Lead Plaintiffs Counsel on January 26, 2005. The PSLRA provides for a stay of discovery in federal securities fraud lawsuits during the pendency of any motion to dismiss:

In any .private action arising under this chapter, all discovery and other proceedings shall be stayed during the pendency of the motion to dismiss, unless the court finds.upon the motion of any party that particularized discovery is necessary to preserve evidence or to prevent undue prejudice to that party.

15 U.S.C. § 78u-4(b)(3)(B). Thus, any discovery in In re Cardinal Health Securities Litigation is presumptively stayed during “the pendency of a motion to dismiss.” 3 Id.

The target of Defendants’ Motion for a Partial Stay is Staehr v. Walter, No. 02-CVG-11-639, a pending state court shareholder derivative action against Cardinal’s officers and directors in the Common Pleas Court of Delaware County, Ohio *871 (“state court”). 4 The original complaint in Staehr was filed on November 8, ,2002. It alleged that the state court defendants (“State Defendants”) breached their fiduciary duties in connection with Cardinal’s acquisition of Syncor International Corporation (“Syncor”) in 2002. An Amended Verified Derivative Complaint was filed on March 21, 2003, which acknowledged that Cardinal had remedied the allegations set forth in the first complaint, but contained new allegations that State Defendants were improperly indemnifying Monty Fu, Syncor’s former board chairman. In April 2003, the Wall Street Journal published an article regarding alleged accounting manipulations at Cardinal; consequently, the state court plaintiff (“Staehr” or “State Plaintiff’) filed a Second Amended Complaint on June 3, 2003, alleging that State Defendants prematurely recognized a $22 million litigation settlement and breached their fiduciary duties by engaging in insider trading and other accounting improprieties. The state court denied State Defendants’ motion to dismiss on November 20, 2003 and set a trial date of September 26, 2005.

State Plaintiff filed her First Request for Production of Documents on December 5, 2002 and her Second Request for Production of Documents on December 26, 2003. Specifically, State Plaintiff requested documents relating to investigations by the Securities and Exchange Commission and the Department of Justice, Cardinal’s communications with accounting entities, and Cardinal’s accounting methods for the settlement of anti-trust litigation involving vitamins (“Vitamin Settlement”). According to State Plaintiff, State Defendants “delayed their production of responsive documents for nearly two years.” (Pl. Resp. at 3). Eventually, State Plaintiff filed a Motion to Compel State Defendants to respond to State Plaintiffs First and Second Request for Production of Documents, which the- Court granted on February 8, 2005, with the caveat that the court’s order was “subject to any Federal District Court stay on portions of discovery requests.” Staehr v. Walter, No. 02-CVG-11-639 (Feb. 8, 2005) (Judgment Entry Granting Plaintiffs Motion to Compel).

- On January 28, 2005, Defendants filed this Motion for Partial Stay of Overlapping State Court Proceedings, asking this Court to enter an Order staying all proceedings and/or discovery in Staehr relating to the accounting issues raised in the pending federal securities complaints. Defendants further request that the stay, if granted, remain in place until the Court decides any dismissal motion in the pending federal securities action. If the case survives Defendants’ dismissal motion, Defendants ask that discovery in Staehr be coordinated with the federal action. 5

III. ANALYSIS

Defendants seek a partial stay of discovery in the pending state court derivative suit and base their request on 15 U.S.C. § 78u-4(b)(3)(D), entitled “Circumvention of stay of discovery,” which provides as follows:

Upon a proper showing, a court may stay discovery proceedings in any pri *872 vate action in a State court, as necessary-in aid of its jurisdiction, or to protect or' effectuate its judgments, in an action subject to a stay of discovery pursuant to this paragraph.

15 U.S.C. § 78u-4(b)(3)(D). Section 78u-3(b)(3)(D) was adopted as part of the Securities Litigation Uniform Standards Act of 1998 (“SLUSA”), Pub.L. 105-353, 112 Stat. 3227, which was enacted in 1998 “to close a perceived gap in the PSLRA.” In re DPL Inc., Sec. Litig., 247 F.Supp.2d 946, 947 (S.D.Ohio 2003).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Taylor v. Fernandes
2018 NCBC 4 (North Carolina Business Court, 2018)
In Re DOT Hill Systems Corp. Securities Litigation
594 F. Supp. 2d 1150 (S.D. California, 2008)
In Re Maxim Integrated Products, Inc., Deriv. Lit.
574 F. Supp. 2d 1046 (N.D. California, 2008)

Cite This Page — Counsel Stack

Bluebook (online)
365 F. Supp. 2d 866, 2005 U.S. Dist. LEXIS 3042, 2005 WL 894693, Counsel Stack Legal Research, https://law.counselstack.com/opinion/in-re-cardinal-health-inc-securities-litigation-ohsd-2005.